Baumal Caroline 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Sale
Common Stock
2026-01-05$25.53/sh−3,020$77,097→ 91,206 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 3, 2026.
- [F2]This includes 925 shares from October 31, 2025 ESPP purchase.